Viewing Study NCT03903705

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2026-03-01 @ 6:03 AM
Study NCT ID: NCT03903705
Status: COMPLETED
Last Update Posted: 2025-04-06
First Post: 2019-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: : A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid Tumors
Sponsor: Hutchmed
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fruquintinib View
None Sintilimab View
None VEGFR View
None PD-1 View
None Solid Tumor View